(ESTE, GNOM, CPRX) CRWENewswire Stocks In Action
Complete Genomics Inc- GNOM - reported that it has been selected by Mayo Clinic’s Center for Individualized Medicine to provide outsourced whole human genome sequencing. On its third quarter fiscal 2012, Earthstone Energy Inc - ESTE - posted net income of $1,152,000, compared to $74,000 in the same period the prior year. Catalyst Pharmaceutical Partners Inc - CPRX - reported that the European Commission has granted orphan medicinal product designation for the company’s investigational-drug, CPP-115, for the treatment of West Syndrome (infantile spasms).

*********************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://crwenewswire.com/disclaimer).

ユーザー：karmastock
再生時間：00:01:11
投稿日時：12/02/14 4:41
カテゴリ：ビジネス全般 
タグ： GNOM  ESTE  CPRX  Nasdaq:GNOM  Amex:ESTE  Nasdaq:CPRX 

[ 前ページへ戻る ]